Tags

Type your tag names separated by a space and hit enter

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
Mov Disord. 2012 Oct; 27(12):1522-9.MD

Abstract

Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45. Early-onset Parkinson's disease (EOPD) patients have a higher familial recurrence risk than late-onset patients, and 3 main recessive EOPD genes have been described. We aimed to establish the prevalence of mutations in these genes in a UK cohort and in previous studies. We screened 136 EOPD probands from a high-ascertainment regional and community-based prevalence study for pathogenic mutations in PARK2 (parkin), PINK1, PARK7 (DJ-1), and exon 41 of LRRK2. We also carried out a systematic review, calculating the proportion of cases with pathogenic mutations in previously reported studies. We identified 5 patients with pathogenic PARK2, 1 patient with PINK1, and 1 with LRRK2 mutations. The rate of mutations overall was 5.1%. Mutations were more common in patients with age at onset (AAO) < 40 (9.5%), an affected first-degree relative (6.9%), an affected sibling (28.6%), or parental consanguinity (50%). In our study EOPD mutation carriers were more likely to present with rigidity and dystonia, and 6 of 7 mutation carriers had lower limb symptoms at onset. Our systematic review included information from >5800 unique cases. Overall, the weighted mean proportion of cases with PARK2 (parkin), PINK1, and PARK7 (DJ-1) mutations was 8.6%, 3.7%, and 0.4%, respectively. PINK1 mutations were more common in Asian subjects. The overall frequency of mutations in known EOPD genes was lower than previously estimated. Our study shows an increased likelihood of mutations in patients with lower AAO, family history, or parental consanguinity.

Authors+Show Affiliations

MRC Centre for Neuropsychiatric Genetics and Genomics, Department of Neurology, School of Medicine, Cardiff University, Cardiff, United Kingdom.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review
Systematic Review

Language

eng

PubMed ID

22956510

Citation

Kilarski, Laura L., et al. "Systematic Review and UK-based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in Early-onset Parkinson's Disease." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 27, no. 12, 2012, pp. 1522-9.
Kilarski LL, Pearson JP, Newsway V, et al. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Mov Disord. 2012;27(12):1522-9.
Kilarski, L. L., Pearson, J. P., Newsway, V., Majounie, E., Knipe, M. D., Misbahuddin, A., Chinnery, P. F., Burn, D. J., Clarke, C. E., Marion, M. H., Lewthwaite, A. J., Nicholl, D. J., Wood, N. W., Morrison, K. E., Williams-Gray, C. H., Evans, J. R., Sawcer, S. J., Barker, R. A., Wickremaratchi, M. M., ... Morris, H. R. (2012). Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society, 27(12), 1522-9. https://doi.org/10.1002/mds.25132
Kilarski LL, et al. Systematic Review and UK-based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in Early-onset Parkinson's Disease. Mov Disord. 2012;27(12):1522-9. PubMed PMID: 22956510.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. AU - Kilarski,Laura L, AU - Pearson,Justin P, AU - Newsway,Victoria, AU - Majounie,Elisa, AU - Knipe,M Duleeka W, AU - Misbahuddin,Anjum, AU - Chinnery,Patrick F, AU - Burn,David J, AU - Clarke,Carl E, AU - Marion,Marie-Helene, AU - Lewthwaite,Alistair J, AU - Nicholl,David J, AU - Wood,Nicholas W, AU - Morrison,Karen E, AU - Williams-Gray,Caroline H, AU - Evans,Jonathan R, AU - Sawcer,Stephen J, AU - Barker,Roger A, AU - Wickremaratchi,Mirdhu M, AU - Ben-Shlomo,Yoav, AU - Williams,Nigel M, AU - Morris,Huw R, Y1 - 2012/09/06/ PY - 2011/10/27/received PY - 2012/06/26/revised PY - 2012/07/12/accepted PY - 2012/9/8/entrez PY - 2012/9/8/pubmed PY - 2013/4/20/medline SP - 1522 EP - 9 JF - Movement disorders : official journal of the Movement Disorder Society JO - Mov Disord VL - 27 IS - 12 N2 - Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45. Early-onset Parkinson's disease (EOPD) patients have a higher familial recurrence risk than late-onset patients, and 3 main recessive EOPD genes have been described. We aimed to establish the prevalence of mutations in these genes in a UK cohort and in previous studies. We screened 136 EOPD probands from a high-ascertainment regional and community-based prevalence study for pathogenic mutations in PARK2 (parkin), PINK1, PARK7 (DJ-1), and exon 41 of LRRK2. We also carried out a systematic review, calculating the proportion of cases with pathogenic mutations in previously reported studies. We identified 5 patients with pathogenic PARK2, 1 patient with PINK1, and 1 with LRRK2 mutations. The rate of mutations overall was 5.1%. Mutations were more common in patients with age at onset (AAO) < 40 (9.5%), an affected first-degree relative (6.9%), an affected sibling (28.6%), or parental consanguinity (50%). In our study EOPD mutation carriers were more likely to present with rigidity and dystonia, and 6 of 7 mutation carriers had lower limb symptoms at onset. Our systematic review included information from >5800 unique cases. Overall, the weighted mean proportion of cases with PARK2 (parkin), PINK1, and PARK7 (DJ-1) mutations was 8.6%, 3.7%, and 0.4%, respectively. PINK1 mutations were more common in Asian subjects. The overall frequency of mutations in known EOPD genes was lower than previously estimated. Our study shows an increased likelihood of mutations in patients with lower AAO, family history, or parental consanguinity. SN - 1531-8257 UR - https://www.unboundmedicine.com/medline/citation/22956510/Systematic_review_and_UK_based_study_of_PARK2__parkin__PINK1_PARK7__DJ_1__and_LRRK2_in_early_onset_Parkinson's_disease_ L2 - https://doi.org/10.1002/mds.25132 DB - PRIME DP - Unbound Medicine ER -